Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04245176

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer This research study involves an expedited and surgery-specific form of genetic counseling. The names of the study methods involved in this trial are/is: * Quantitative genetic counseling (discussion is guided by tables and graphs) * Standard genetic counseling

Detailed description

* The research study procedures include screening for eligibility and study interventions including evaluations and follow up visits * After receiving genetic testing, participants will be placed into one of two counseling methodology groups: * Standard genetic counseling: Standard of care discussion * Quantitative genetic counseling: Discussion is guided by tables and graphs. * Participants will be on the research study for up to six months, with an optional extension to two years. * It is expected that about 450 people will participate. * This research study is a Feasibility Study, which is the first-time investigators are examining this form of genetic counseling. * This is a randomized study. Randomization means being put into a group by chance. It is like flipping a coin. Neither the participant nor the Investigator will choose the group the participant is assigned to.

Conditions

Interventions

TypeNameDescription
BEHAVIORALStandard Genetic CounselingStandard genetic counseling: Standard of care discussion
BEHAVIORALQuantitative Genetic CounselingQuantitative genetic counseling: Discussion is guided by tables and graphs.

Timeline

Start date
2020-01-31
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2020-01-28
Last updated
2025-03-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04245176. Inclusion in this directory is not an endorsement.